Mitochondrial Isolation: Major Methods, Applicability Boundaries, and Quality Control
Mitochondrial Isolation: Major Methods, Applicability Boundaries, and Quality Control
Mitochondrial isolation is a fundamental step in metabolic analysis, apoptosis research, drug toxicity evaluation, and studies of mitochondrial nucleic acids and proteomics. Its real criterion of success is not whether a pellet is obtained, but whether the resulting fraction simultaneously meets the requirements for purity, structural integrity, and functional preservation. Differential centrifugation, density gradient centrifugation, and magnetic bead/affinity-based isolation each correspond to different experimental goals and should be selected according to sample characteristics and downstream applications.
Keywords: mitochondrial isolation; differential centrifugation; density gradient centrifugation; magnetic bead separation; mitochondrial purification; mitochondrial integrity; quality control
1. Technical Targets and Experimental Significance of Mitochondrial Isolation
1.1 Technical targets
(1) Mitochondria are not uniform particles
In mitochondrial isolation experiments, the true technical target is not an abstract entity called “mitochondria,” but rather mitochondrial populations existing in different metabolic states, with different degrees of membrane integrity and different morphological backgrounds. In different tissues, different cell types, and under different treatment conditions, mitochondria vary substantially in size, density, membrane fragility, cristae structure, and their associations with other organelles. Therefore, mitochondrial isolation is not a single template-based operation, but an experimental process that must be adapted to sample properties.
(2) Downstream applications determine the isolation standard
If the sample is intended for Western blotting or routine protein detection, the main emphasis is usually on enrichment of mitochondrial components. If the sample is intended for oxygen consumption analysis, membrane potential measurement, mPTP opening, calcium uptake, respiratory chain activity assays, or metabolic flux studies, then enrichment alone is insufficient; preservation of outer and inner membrane integrity, maintenance of coupling status, and minimization of cytosolic contamination are also required. Therefore, mitochondrial isolation quality cannot be evaluated independently of the downstream experiment.
1.2 Significance of application
(1) Metabolic research
Mitochondria are the core site of the tricarboxylic acid cycle and oxidative phosphorylation. By isolating mitochondria and measuring ATP generation efficiency, respiratory chain activity, and key enzyme activities, researchers can obtain direct functional readouts for studies of diabetes, obesity, metabolic syndrome, and related conditions.
(2) Cell apoptosis and stress pathway research
Mitochondria participate in cytochrome c release, membrane potential changes, ROS accumulation, and mPTP opening. Analyzing isolated mitochondria helps establish experimental models for apoptosis, oxidative stress, and damage signaling pathways.
(3) Drug screening and toxicity evaluation
Many drugs affect mitochondrial function by inhibiting the respiratory chain, disrupting membrane potential, increasing ROS, or damaging mtDNA. Measurement of oxygen consumption, membrane potential, and related enzyme activities after mitochondrial isolation helps assess mitochondrial toxicity and mechanism of action.
(4) Mitochondrial nucleic acid and proteomics research
mtDNA, mitochondrial RNA, and mitochondrial protein complexes all have independent research value. High-quality mitochondrial isolation is a prerequisite for mtDNA sequencing, mitochondrial transcription analysis, and proteomic studies.
2. Basic Principles of Mitochondrial Isolation
2.1 Isolation logic
(1) Separation based on physical differences among organelles
The core principle of traditional mitochondrial isolation is to exploit differences among organelles in size, density, sedimentation behavior, and buoyant density, and then achieve separation stepwise through mechanical disruption, differential centrifugation, and density gradient purification.
(2) The isolation process generally contains at least three levels
Mitochondrial isolation is not achieved simply by “one centrifugation step.” It usually includes three levels: ① releasing mitochondria while minimizing membrane damage; ② removing nuclei, unbroken cells, and large debris to obtain a crude mitochondrial fraction; ③ further washing, refining, or specifically enriching the fraction according to experimental needs.
2.2 Core evaluation parameters
(1) Purity
This refers to whether the obtained fraction consists predominantly of mitochondrial components while minimizing contamination from endoplasmic reticulum, lysosomes, peroxisomes, plasma membrane, and cytosol.
(2) Integrity
This refers to whether the outer and inner mitochondrial membranes remain intact during isolation. For functional studies, integrity is often more important than yield.
(3) Recovery
This refers to the degree to which mitochondria are retained during the isolation process. High-purity methods are often accompanied by reduced recovery, so purity and recovery usually involve a methodological trade-off.
(4) Functional preservation
This refers to whether isolated mitochondria still retain respiratory activity, membrane potential, enzyme activity, and ion homeostasis. If the sample is intended for functional experiments, a visible pellet or enrichment of marker proteins alone is not sufficient.
3. Differential Centrifugation
3.1 Principle of the method
(1) Stepwise separation based on sedimentation rate
Differential centrifugation uses different centrifugal speeds and durations to sequentially separate nuclei, unbroken cells, large debris, mitochondria, and other smaller organelles. Its logic is not to obtain highly purified mitochondria in a single step, but to progressively enrich them through multiple centrifugation conditions.
(2) The principal method for crude mitochondrial extraction
Differential centrifugation is the most universal and fundamental method for mitochondrial isolation. Whether or not density gradient purification is subsequently used, differential centrifugation is typically the prerequisite step.
3.2 Operational workflow and control points
(1) Sample preparation
Fresh viable cells or fresh tissues are preferred. Freeze-thaw cycles easily damage mitochondrial membranes and are particularly unsuitable for downstream respiration, membrane potential, and mPTP experiments. All procedures should be performed as far as possible at 4°C to reduce protease activity and functional loss caused by ongoing metabolism.
(2) Hypotonic swelling and homogenization
For most cultured cells, cells may first be resuspended in hypotonic buffer to induce moderate swelling, followed by mechanical disruption with a homogenizer. The purpose of hypotonic treatment is to reduce the shear force required for homogenization, not to directly lyse the cells. Homogenization should be performed in stages, and the extent of breakage should be checked microscopically. Ideally, most cells should be disrupted while a small proportion remain incompletely broken, to avoid excessive shearing that damages the mitochondrial outer membrane.
(3) Restoration of isotonic conditions
After hypotonic swelling and homogenization, a concentrated isotonic buffer should be added promptly to restore osmotic stability and prevent mitochondrial swelling and membrane rupture caused by prolonged hypotonic exposure. After isotonicity is restored, the total volume is adjusted with 1× isotonic buffer before centrifugation.
(4) Low-speed centrifugation to remove large particles
A low-speed centrifugation step is first used to remove nuclei, unbroken cells, and large debris. The pellet is generally discarded, and the supernatant is transferred to a new tube. Depending on the degree of cell disruption, this step may be repeated one or two times to improve the purity of the crude mitochondrial fraction.
(5) Medium-to-high-speed centrifugation to sediment mitochondria
The supernatant is then subjected to medium-to-high-speed centrifugation, during which mitochondria sediment and form a crude pellet. This pellet is usually a mitochondria-enriched fraction but may still contain some endoplasmic reticulum, lysosomes, and membrane fragments.
(6) Resuspension and washing
The crude pellet should be gently resuspended in isotonic buffer, followed by one or two additional medium-to-high-speed wash centrifugation steps to reduce cytosolic proteins, small molecules, and nonspecific co-sedimenting contaminants. Vigorous shaking or harsh pipetting should be avoided during resuspension, otherwise mitochondrial structure may be further damaged.
3.3 Method characteristics and suitable applications
(1) Advantages
The major advantages of differential centrifugation are strong general applicability, relatively simple operation, larger sample throughput, and low dependence on specialized instruments. It is suitable for most cultured cells and routine tissue samples, as well as for most protein analyses and some routine functional experiments.
(2) Limitations
This method generally yields only a crude mitochondrial fraction with limited purity. If the sample contains abundant endoplasmic reticulum, lysosomes, or membrane fragments, these may co-sediment and interfere with high-precision metabolic and omics experiments.
4. Density Gradient Centrifugation
4.1 Principle of the method
(1) Further purification based on buoyant density differences
Density gradient centrifugation is usually performed after crude mitochondria have been obtained by differential centrifugation. By establishing a sucrose, Percoll, or other gradient medium, mitochondria and other organelles can be further separated according to differences in buoyant density. The point is not simply “another centrifugation step,” but the use of different equilibrium positions within the gradient to achieve higher purity.
(2) Essentially a refinement step
Density gradient centrifugation is rarely used alone as the starting isolation method. More commonly, it serves as a purification step after differential centrifugation to reduce contaminants in crude mitochondrial preparations.
4.2 Operational workflow and control points
(1) Obtaining the crude mitochondrial fraction
A crude mitochondrial pellet is first obtained by differential centrifugation and then gently resuspended in an appropriate buffer. The quality of resuspension directly affects loading uniformity and gradient separation quality.
(2) Gradient preparation and sample loading
Depending on the experimental goal, a sucrose gradient or Percoll gradient is prepared. The purpose of the gradient is to create a continuous or layered low-to-high-density environment so that different organelles settle at different positions after centrifugation. During loading, the sample should be added slowly to avoid disturbing the gradient interface.
(3) High-speed centrifugation for stratification
Under relatively high centrifugal force, mitochondria migrate to the position matching their buoyant density, while lighter or heavier contaminating organelles remain at other layers. After centrifugation, distinct layers or interfaces can usually be observed.
(4) Recovery and washing of the target layer
After the mitochondria-enriched layer is collected, it should be washed with isotonic buffer to remove residual gradient medium. If Percoll or high-concentration sucrose is not adequately removed, downstream respiratory or enzymatic assays may be affected.
4.3 Method characteristics and suitable applications
(1) Advantages
The major advantage of density gradient centrifugation is high purity. It can significantly reduce contamination from endoplasmic reticulum, lysosomes, and membrane fragments, making it more valuable for proteomics, lipidomics, respiratory chain complex analysis, metabolomics, and high-precision functional experiments.
(2) Limitations
This method is more time-consuming, prolongs sample handling, and often gives lower recovery than differential centrifugation alone. In addition, gradient preparation and recovery require high operational consistency. Improper handling may reduce mitochondrial function.
5. Magnetic Bead and Affinity-Based Isolation
5.1 Principle of the method
(1) Enrichment based on specific recognition of membrane proteins
Magnetic bead or affinity-based isolation generally uses antibodies, ligands, or tagged systems directed against mitochondrial outer membrane proteins to specifically capture mitochondria, which are then eluted or used directly in downstream analysis. This method does not rely on sedimentation speed, but on molecular recognition.
(2) Specificity rather than physical stratification is the core
Unlike differential or density gradient centrifugation, magnetic bead isolation emphasizes selective capture. It therefore has unique value for low-input samples, specific mitochondrial subpopulations, or experimental settings that require rapid processing.
5.2 Operational workflow and control points
(1) Mild sample lysis
To ensure that outer membrane targets remain accessible for recognition, lysis conditions are usually milder than in standard homogenization, to avoid severe outer membrane damage.
(2) Binding to magnetic beads or affinity matrices
After lysis, the sample is incubated with magnetic beads or affinity materials carrying specific recognition molecules, allowing mitochondria to bind. Incubation conditions must balance binding efficiency with preservation of mitochondrial integrity; overly long incubation may reduce function.
(3) Magnetic separation or elution
A magnetic field or affinity elution condition is then used to separate target mitochondria from the mixed fraction. If the sample is intended for protein detection, analysis may proceed while mitochondria remain bound to the beads; if intended for functional assays, it is necessary to evaluate whether the elution process affects mitochondrial status.
5.3 Method characteristics and suitable applications
(1) Advantages
This method is suitable for low-input samples and for certain experimental designs requiring rapid enrichment with high specificity. For research on particular mitochondrial subpopulations, its selectivity is superior to conventional differential centrifugation.
(2) Limitations
Magnetic bead isolation is expensive, low-yield, and highly dependent on antibody quality and membrane protein accessibility. In addition, some capture systems may affect outer membrane status and may therefore not be suitable for all respiration- and membrane-related experiments.
Table 1. Comparison of the main methods for mitochondrial isolation
Isolation method | Core principle | Advantages | Limitations | Suitable applications |
Differential centrifugation | Differences in sedimentation rate | Simple operation, high sample throughput | Limited purity, prone to organelle co-sedimentation | Routine protein detection, crude functional analysis |
Density gradient centrifugation | Differences in buoyant density | Higher purity, lower contamination | Longer procedure, reduced recovery | Refined functional studies, proteomics |
Magnetic bead/affinity isolation | Targeted capture | High specificity, suitable for small samples | High cost, low yield | Specific subpopulation enrichment, rapid analysis |
6. Quality Evaluation and Experimental Interpretation
6.1 Purity evaluation
(1) Protein marker detection
If the sample is intended for Western blotting, mitochondrial marker proteins and cytoplasmic proteins should be examined simultaneously to evaluate isolation quality. Mitochondrial markers may include VDAC1, COX IV, and DLAT; cytosolic contamination may be assessed using GAPDH, Tubulin, β-actin, and related markers. The most informative result is not simply “mitochondrial proteins were detected,” but rather “mitochondrial markers are enriched while cytoplasmic markers are substantially reduced.”
(2) Nucleic acid marker detection
If the sample is used for nucleic acid studies, qPCR can be used to measure high-abundance and relatively stable mitochondrial RNA or mtDNA targets, such as 12S rRNA, mt-ND1, and mt-ND4, to evaluate mitochondrial nucleic acid enrichment.
6.2 Integrity and functional evaluation
(1) Membrane integrity
If downstream experiments involve membrane potential, mPTP, cytochrome c release, or calcium homeostasis, it is essential to determine whether the mitochondria retain intact membrane structure. Protein enrichment alone cannot demonstrate preservation of membrane function.
(2) Functional state
If the sample is used for metabolic research or drug toxicity evaluation, oxygen consumption, ATP generation, membrane potential, or key enzyme activities should also be assessed. Otherwise, even if a mitochondrial pellet is obtained, it remains unclear whether physiologically relevant function has been preserved.
6.3 Common problems and interpretation
(1) Large pellet but poor function
This usually suggests co-sedimentation of contaminants or excessive homogenization-induced mitochondrial damage. In such cases, purity and membrane integrity should be checked first rather than using pellet amount as the success criterion.
(2) Positive mitochondrial markers but strong cytoplasmic contamination
This indicates that mitochondria have indeed been enriched, but the isolation is impure. In such cases, the priority should be to optimize low-speed clearing and wash steps rather than simply increasing the final sedimentation force.
(3) High purity but insufficient yield
This is commonly seen when gradient purification conditions are too stringent or when starting material is limited. Whether such high purity is necessary should be judged according to downstream needs, or the strategy should be adjusted toward higher recovery.
Table 2. Common abnormalities in mitochondrial isolation experiments and their interpretation
Abnormal finding | Common cause | First priority for evaluation |
Large pellet but poor function | Co-sedimented contaminants, excessive homogenization | Check purity and membrane integrity first |
High mitochondrial markers but also high cytoplasmic proteins | Impure isolation | Prioritize optimization of low-speed clearing and wash steps |
Low recovery | Insufficient homogenization, weak centrifugation conditions | Optimize release and sedimentation conditions first |
High purity but low total yield | Overly stringent gradient or low starting material | Judge whether it meets downstream experimental needs |
Large batch-to-batch variation | Inconsistent sample handling, poor temperature control | Standardize pre-processing workflow first |
7. Related Research Products
Table 3. Products related to mitochondrial isolation and quality control
Catalog No. | Name | Grade and Purity | Corresponding step | Suitable research applications / use |
Mitochondria Isolation Reagent | 2× | Isolation and extraction | Suitable for crude mitochondrial extraction and pre-processing before differential centrifugation; used as a basic reagent for mitochondrial isolation | |
Cell Mitochondria Isolation Kit | BioReagent, for polyacrylamide gel electrophoresis, for protein analysis, for western blot, 50–100T | Isolation and extraction | Suitable for mitochondrial isolation from cultured cells, especially for downstream Western blot and protein enrichment analysis | |
Tissue Mitochondria Isolation Kit | BioReagent, for polyacrylamide gel electrophoresis, for protein analysis, for western blot | Isolation and extraction | Suitable for mitochondrial isolation and protein analysis from liver, brain, heart, skeletal muscle, and other tissue samples | |
Mitochondria Storage Buffer | — | Post-isolation preservation | Suitable for short-term suspension, transport, and state maintenance of isolated mitochondria before downstream experiments | |
Mitochondrial complex I Activity Assay Kit (Micro Method) | BioReagent | Functional quality control | Used to evaluate preservation of Complex I activity and respiratory chain function after isolation | |
Mitochondrial complexⅡ Activity Assay Kit (Micro Method) | BioReagent | Functional quality control | Used to analyze Complex II activity and assess electron transport function in isolated samples | |
Mitochondrial complex Ⅲ Activity Assay Kit (Micro Method) | BioReagent | Functional quality control | Used to evaluate Complex III activity; suitable for post-isolation respiratory chain integrity analysis | |
Mitochondrial complex Ⅳ Activity Assay Kit (Micro Method) | BioReagent | Functional quality control | Used to evaluate Complex IV activity; suitable for oxidative phosphorylation terminal function analysis | |
Mitochondrial complex Ⅴ Activity Assay Kit (Micro Method) | BioReagent | Functional quality control | Used to analyze ATP synthase-related function and evaluate coupling status in isolated mitochondria | |
Mitochondrial Malate Dehydrogenase(mMDH) Activity Assay Kit (UV Micro Method) | BioReagent | Metabolic enzyme activity evaluation | Used to evaluate mitochondrial matrix enzyme activity and preservation of metabolic function after isolation | |
Mitochondrial Malate Dehydrogenase (mMDH) Activity Assay Kit (UV Colorimetric Method) | BioReagent | Metabolic enzyme activity evaluation | Suitable for post-isolation mitochondrial metabolic enzyme activity testing, as an auxiliary indicator of functional preservation | |
Mitochondrial Reactive Oxygen Species (ROS) Production Rate Assay Kit (Fluorometric Method) | BioReagent | Oxidative stress evaluation | Used to detect ROS generation rate in isolated mitochondria and assess sample damage and oxidative status | |
Mitochondrial Membrane Potential Assay Kit (Rhodamine 123) | BioReagent, for cell culture, sterile | Membrane integrity evaluation | Used to detect membrane potential in isolated mitochondria and evaluate inner membrane function and coupling status | |
Mitochondrial Membrane Potential Detection Kit (JC-1) | — | Membrane integrity evaluation | Suitable for membrane potential detection in isolated mitochondria; used as an indicator of integrity and functional state | |
Mitochondrial Membrane Potential Assay Kit (JC-10) | BioReagent | Membrane integrity evaluation | Suitable for quantitative membrane potential detection in isolated mitochondria and complementary use with JC-1 systems | |
JC-1 | ≥95% | Membrane potential detection | Suitable for self-built membrane potential assay systems and inner membrane state analysis of isolated mitochondria | |
JC-10 | ≥95% | Membrane potential detection | Suitable for fluorescence-based membrane potential detection in isolated mitochondria and functional state verification | |
DASPEI mitochondrial fluorescent probe | ≥95% | Staining and visualization | Suitable for fluorescent labeling of mitochondria and auxiliary observation of morphology/localization after isolation | |
Mitochondrion Red Probe (AIE) | BioReagent, for microscope, biological stain, ≥98%(HPLC), 50 mM in DMSO | Staining and visualization | Suitable for mitochondrial staining and auxiliary imaging comparison of mitochondrial status before and after isolation | |
Mito-Tracker Far-Red | BioReagent, ≥95% | Staining and visualization | Suitable for far-red mitochondrial staining and auxiliary analysis of mitochondrial enrichment and distribution | |
MitoScene™ Green I | — | Staining and visualization | Suitable for green fluorescent labeling of mitochondria and imaging-based evaluation in isolated or cellular samples | |
Mito-FerroGreen | — | Post-isolation state evaluation | Used to detect mitochondrial iron status and suitable for combination with metabolic and oxidative stress studies | |
Human Mitochondrial Import Receptor Subunit TOM70 (TOMM70A) ELISA Kit | BioReagent | Purity/enrichment evaluation | Used for quantitative analysis of the mitochondrial outer membrane marker TOMM70A in human samples to assist evaluation of mitochondrial enrichment | |
Human Transcription Factor A, Mitochondrial (TFAM) ELISA Kit | BioReagent | Purity/mitochondrial content evaluation | Suitable for evaluating mitochondrial content and mitochondrial nucleic acid maintenance status in human samples | |
Rat Transcription Factor A, Mitochondrial (TFAM) ELISA Kit | BioReagent | Purity/mitochondrial content evaluation | Suitable for evaluation of mitochondrial content after isolation in rat samples | |
Mouse Transcription Factor A, Mitochondrial (TFAM) ELISA Kit | BioReagent | Purity/mitochondrial content evaluation | Suitable for evaluation of mitochondrial enrichment and mitochondrial quality state in mouse samples |
Table 4. Products related to evaluation of mitochondrial isolation purity and contamination
Catalog No. | Name | Grade and Purity | Marker category | Use in mitochondrial isolation |
VDAC1/Porin Antibody | ExactAb™, validated, recombinant, see COA | Mitochondrial outer membrane positive marker | Suitable for Western blot detection of the outer membrane protein VDAC1 to determine whether mitochondrial components have been successfully enriched | |
Human Voltage-dependent Anion-selective Channel 1 (VDAC1) ELISA Kit | BioReagent | Mitochondrial outer membrane positive marker | Suitable for quantitative detection of VDAC1 in human samples as an auxiliary indicator of mitochondrial content and enrichment efficiency | |
Rat Voltage-dependent Anion-selective Channel 1 (VDAC1) ELISA Kit | BioReagent | Mitochondrial outer membrane positive marker | Suitable for quantitative analysis of VDAC1 in rat samples to assist evaluation of mitochondrial isolation quality | |
Mouse Voltage-dependent Anion-selective Channel 1 (VDAC1) ELISA Kit | BioReagent | Mitochondrial outer membrane positive marker | Suitable for quantitative analysis of outer membrane markers in mouse samples | |
COX IV Mouse mAb | ExactAb™, Validated, 2.0 mg/mL | Mitochondrial inner membrane positive marker | Suitable for detection of the inner membrane protein COX IV and can be used together with VDAC1 to assess mitochondrial isolation purity | |
COX IV Mouse mAb (HRP) | ExactAb™, validated, high performance, 0.5 mg/mL | Mitochondrial inner membrane positive marker | Suitable for direct HRP-based detection and rapid validation of mitochondrial marker proteins | |
Recombinant COX IV Antibody | ExactAb™, Validated, Recombinant, High performance, 0.5 mg/mL | Mitochondrial inner membrane positive marker | Suitable for validation of inner membrane markers and repeated detection of isolated samples with high consistency | |
GAPDH Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, high performance, see COA | Cytoplasmic contamination negative marker | Suitable for assessing whether cytoplasmic components are mixed into the isolated sample; obvious GAPDH signal in the mitochondrial fraction suggests impurity | |
GAPDH Mouse mAb (HRP) | ExactAb™, validated, 0.5 mg/mL | Cytoplasmic contamination negative marker | Suitable for HRP-based rapid evaluation of cytoplasmic contamination | |
beta Actin Antibody | ExactAb™, Validated, Azide Free, High performance, 1.0 mg/mL | Cytoplasmic/cytoskeletal contamination negative marker | Suitable for determining whether obvious cytoplasmic and cytoskeletal components remain in the isolated sample | |
beta Actin Mouse mAb (HRP) | ExactAb™, high performance, validated, azide-free, 0.5 mg/mL | Cytoplasmic/cytoskeletal contamination negative marker | Suitable for rapid detection of β-actin contamination and comparison with mitochondrial positive markers | |
Calnexin Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, high performance, ≥95%(SDS-PAGE), 0.5 mg/mL | Endoplasmic reticulum contamination negative marker | Suitable for determining whether endoplasmic reticulum components are mixed into mitochondrial samples; an important auxiliary indicator of mitochondrial purity | |
Recombinant Calnexin Antibody | Knockdown validated | Endoplasmic reticulum contamination negative marker | Suitable for Calnexin detection where higher specificity is required to identify ER co-sedimentation | |
LAMP1 Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, ≥95%(SDS-PAGE), 1.0 mg/mL | Lysosomal contamination negative marker | Suitable for determining whether lysosomal contamination is present in mitochondrial fractions, especially in tissue sample quality evaluation | |
Recombinant LAMP1 Antibody | ExactAb™, Validated, recombinant, 0.2 mg/mL | Lysosomal contamination negative marker | Suitable for lysosomal contamination validation and as a complementary option to routine LAMP1 monoclonal antibodies |
The key to mitochondrial isolation is not obtaining a pellet, but determining whether the resulting fraction truly satisfies the requirements for purity, integrity, and preserved function. Differential centrifugation, density gradient centrifugation, and magnetic bead or affinity-based isolation each have clear technical boundaries and should be chosen according to sample properties and downstream goals. Quality evaluation after isolation should simultaneously cover mitochondrial positive markers and non-mitochondrial contamination markers.
For more related articles, please see below:
[1] Experiments on oxidation and phosphorylation in isolated mitochondria
[2] Experiments on live staining of mitochondria in cells
[3] Experiments on the hierarchical separation of mitochondria
